Active Ingredients and Microorganisms

Documentation and optimisation of new products in development

Bioneer has developed a range of technology platforms for use in the development of active ingredients and microorganisms including probiotics.

One approach undertaken by Bioneer is to use in vitro models to predict in vivo effects of ingredients and probiotics. Such in vitro data can be used in optimisation of the products during development, in assuring the product quality during manufacturing, and as part of the documentation for health benefit claims.


	Development of active ingredients	Development of probiotics	Optimisation of microorganisms
Intestinal models		Biological barrier models
Immune models	Human dendritic cell models Murine dendritic cell models PBMC models	Human dendritic cell models Murine dendritic cell models PBMC models
Analytical techniques			Microbial strain optimization package
Formulation	Pharmaceutical formulation
Screening techniques		Probiotic bacteria characterization package	Microbial strain optimization package